Physician

Aaron Coulon, M.D.

According to 2025 Medicare claims, Aaron Coulon, M.D. (NPI: 1346773108) practices dermatology in the New Orleans-Metairie, LA market, with the plurality of this provider's patient population coming from Jefferson, LA. This provider's primary affiliated billing organization is OCHSNER CLINIC LLC (NPI: 1538151428; TIN: 720276883) and primary practice location at 70121-2429. Coulon is affiliated with the Ochsner Accountable Care Network, LLC (ACO ID: A1535), participating under the MSSP model.

Coulon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 356 traditional Medicare patients, billed 1,552 HCPCS/CPT codes, and received $45,327 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 1,797 prescription claims across 624 beneficiaries totaling $617,224 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 2 records totaling $171. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $7,764 to $617,224. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$32K$64K2021 Medicare payment: $5,869 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $63,542 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $33,486 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $45,327 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20213692$5,869
20223561,297$63,542
20232741,058$33,486
20243561,552$45,327

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$309K$617K2017 Drug cost: $7,764 (USD; Tot_Drug_Cst)2018 Drug cost: $101,550 (USD; Tot_Drug_Cst)2019 Drug cost: $171,172 (USD; Tot_Drug_Cst)2020 Drug cost: $122,089 (USD; Tot_Drug_Cst)2021 Drug cost: $121,183 (USD; Tot_Drug_Cst)2022 Drug cost: $211,495 (USD; Tot_Drug_Cst)2023 Drug cost: $214,151 (USD; Tot_Drug_Cst)2024 Drug cost: $617,224 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20172768$7,764
2018117421$101,550
2019104319$171,172
202071228$122,089
2021137356$121,183
20224601,201$211,495
20235331,335$214,151
20246241,797$617,224

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more114114$54
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more136169$46
17000Destruction of precancer skin growth, 1 growth140179$36
11102Biopsy of related skin growth, first growth102119$19
17003Destruction of precancer skin growth, 2-14 growths109538$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa11700$214,025
Dupixent PenDupilumab21546$80,157
PimecrolimusPimecrolimus21620$8,884
TacrolimusTacrolimus701,837$8,517
Clobetasol PropionateClobetasol Propionate2587,334$7,059

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$171E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Aaron Coulon, M.D.?

Tedicare shows public-source Medicare data for Aaron Coulon, M.D. (NPI 1346773108), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Coulon, M.D. have ACO affiliation data?

Aaron Coulon, M.D. is shown with ACO affiliation data for Ochsner Accountable Care Network, LLC (MSSP, ACO ID A1535).

What billing organization is linked to Aaron Coulon, M.D.?

Aaron Coulon, M.D. is linked to OCHSNER CLINIC LLC (billing NPI 1538151428) in the available physician profile data.

Does Aaron Coulon, M.D. have Open Payments data?

Aaron Coulon, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.